Skip to main content
Premium Trial:

Request an Annual Quote

Michael Barber, David Snyder, Arthur Stytkowski

GE appointed Michael Barber as chief technology officer of GE Healthcare and a vice president of technology, diagnostic imaging, the company said this week.
He has been the general manager of technology since May 2005 and has been with GE since 1981. He held other positions in GE Healthcare, including general manager for components engineering and general manager for global components operations.
Barber received his bachelors' degree in electrical engineering from the Milwaukee School of Engineering.

NimbleGen Systems named David Snyder as chief financial officer last week.
He has over 15 years experience as a chief financial officer for companies spanning several industries, including technology, real estate, and diversified manufacturing.
Snyder graduated from Harvard Business School with high honors and was designated a Baker Scholar. He received his BA from Ottawa University.

DNAPrint Genomics retained Arthur Stytkowski as a consultant on scientific, medical, regulatory, and patent issues, the company said last week.
Stytkowski is the director of the laboratory for cell and molecular biology at Beth Israel Deaconess Medical Center, an affiliate of Harvard Medical School. He is an associate professor in the department of medicine at Harvard Medical School and a member of the division of hematology and oncology at BIDMC.

Filed under

The Scan

Genetic Risk Factors for Hypertension Can Help Identify Those at Risk for Cardiovascular Disease

Genetically predicted high blood pressure risk is also associated with increased cardiovascular disease risk, a new JAMA Cardiology study says.

Circulating Tumor DNA Linked to Post-Treatment Relapse in Breast Cancer

Post-treatment detection of circulating tumor DNA may identify breast cancer patients who are more likely to relapse, a new JCO Precision Oncology study finds.

Genetics Influence Level of Depression Tied to Trauma Exposure, Study Finds

Researchers examine the interplay of trauma, genetics, and major depressive disorder in JAMA Psychiatry.

UCLA Team Reports Cost-Effective Liquid Biopsy Approach for Cancer Detection

The researchers report in Nature Communications that their liquid biopsy approach has high specificity in detecting all- and early-stage cancers.